$67.22
-5.59-7.68%
Last update: Nov 5, 4:00 PM
Monopar Therapeutics Inc
MNPRNASDAQ
The average analyst price target for Monopar Therapeutics is $97.53, 45.1% above the current price. Of 14 analysts, 12 rate it Buy and 2 Hold. Targets range from $10 to $145. The latest change came on Sep 11, 2026, when Barclays raised its price target on Monopar Therapeutics from $128 to $145 and kept an Overweight rating.
Price Target Range — 10 Quarters
Analyst Consensus — 14 Analysts
Rating Trend — Last 9 Months
